1 enrolling by invitation, 1 not yet recruiting, 1 recruiting. 1 Early Phase 1, 1 Phase 1, 1 Phase 2, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Small-for-size Syndrome: new trials by email Literature Review of Small-for-size Syndrome trials Research Report on Small-for-size Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety, Tolerability, and Preliminary Efficacy of Hepatocyte-like Cell Injection for the Prevention and Treatment of Small-for-Size Syndrome Hepatocyte-like cell administration via rectus sheath intramuscular injection - Small-for-size Syndrome | Early Phase 1 | Enrolling by invitation | Zhi-Jun Zhu | 12 | 2025-12-17 | 2026-04-15 |
| Safety and Tolerability Study of a Novel Bioartificial Liver in Liver Failure and Small-for-Size Syndrome Chemically induced pluripotent stem cells biological Artificial Liver - Liver Failure, Small-for-Size Syndrome | Phase 1 / Phase 2 | Recruiting | Beijing Friendship Hospital | 12 | 2025-12-01 | 2026-04-20 |
| Octreotide vs. Splenic Artery Ligation for Portal Flow Modulation in Living Donor Liver Transplants (SCALOP Trial) Octreotide (drug), Splenic Artery Ligation (SAL) - Small-for-Size Syndrome | Phase 4 | Not yet recruiting | King Faisal Specialist Hospital & Research Center | 80 | 2025-06-01 | 2025-05-15 |
Liver Failure (1)
Digestive System Diseases (1) · Hepatic Insufficiency (1) · Liver Diseases (1)
Octreotide (1) · Pharmaceutical Preparations (1)
Beijing Friendship Hospital (1) · King Faisal Specialist Hospital & Research Center (1) · Zhi-Jun Zhu (1)
China (2) · Saudi Arabia (1)
Dieter C. Broering, MD, PhD (1) · Dimitri A. Raptis, MD, MSc, PhD (1) · Massimo Malago, MD, PhD (1)